Oh S Y, Lee C H, Ku Y S
College of Pharmacy, Ewha Womans University, Seodaemun-Gu, Seoul, Korea.
J Pharm Pharmacol. 2000 Sep;52(9):1099-103. doi: 10.1211/0022357001775029.
The pharmacokinetics and hepatoprotective effects of 2-methylaminoethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybip henyl-2-carboxylic acid-2'-carboxylate monohydrochloride (DDB-S) have been investigated in rats with CCl4-induced acute hepatic failure. To study the pharmacokinetics of DDB-S, rats were divided into a control group and a CCl4-intoxicated group. DDB-S 50 mg kg(-1) was administered by intravenous bolus injection to both groups of rats. In the CCl4-intoxicated rats the plasma concentrations of DDB-S were significantly higher, the area under the plasma concentration-time curve from time zero to time infinity was significantly greater (6-46 vs 3.34 mg min mL(-1)), and the total body (7.74 vs 15.0 mL min(-1) kg(-1)), renal (2.55 vs 5.10 mL min(-1) kg(-1)), nonrenal (5.07 vs 9.65 mL min(-1) kg(-1)), and biliary (1.48 vs 2.69 mL min(-1) kg(-1)) clearances were significantly slower compared with the control rats. This could be due to decreased hepatic cytochrome P450 activity and impaired kidney function induced by CCl4. To study the hepatoprotective effects of DDB-S, rats were divided into three groups, control rats and CCl4-intoxicated rats with or without DDB-S pretreatment (50 mg kg(-1) i.p.). The effects of DDB-S pretreatment on CCl4-induced liver injury were considerable; the serum levels of alanine transaminase, aspartate transaminase, and alkaline phosphatase were significantly lower by 54.3, 44.6 and 67.2%, respectively, compared with the CCl4-intoxicated-only group. In an in-vitro study, rat hepatocytes were exposed to fresh medium containing 10 mM CCl4 and various concentrations of DDB-S (10 or 100 microg mL(-1)). The levels of alanine transaminase and aspartate transaminase in the medium were measured as an indicator of hepatocyte injury. DDB-S dose-dependently decreased the levels of alanine transaminase and aspartate transaminase compared with CCl4-intoxication only. These results indicate that DDB-S has hepatoprotective activity.
研究了2-甲氨基乙基-4,4'-二甲氧基-5,6,5',6'-亚甲基二氧基联苯-2-羧酸-2'-羧酸盐单盐酸盐(DDB-S)在四氯化碳诱导的急性肝衰竭大鼠中的药代动力学和肝保护作用。为研究DDB-S的药代动力学,将大鼠分为对照组和四氯化碳中毒组。两组大鼠均通过静脉推注给予50 mg kg(-1)的DDB-S。在四氯化碳中毒大鼠中,DDB-S的血浆浓度显著更高,从时间零点到无穷大的血浆浓度-时间曲线下面积显著更大(6-46对3.34 mg min mL(-1)),全身清除率(7.74对15.0 mL min(-1) kg(-1))、肾脏清除率(2.55对5.10 mL min(-1) kg(-1))、非肾脏清除率(5.07对9.65 mL min(-1) kg(-1))和胆汁清除率(1.48对2.69 mL min(-1) kg(-1))与对照大鼠相比显著减慢。这可能是由于四氯化碳诱导的肝细胞色素P450活性降低和肾功能受损所致。为研究DDB-S的肝保护作用,将大鼠分为三组,即对照大鼠以及经或未经DDB-S预处理(50 mg kg(-1)腹腔注射)的四氯化碳中毒大鼠。DDB-S预处理对四氯化碳诱导的肝损伤作用显著;与仅四氯化碳中毒组相比,血清丙氨酸转氨酶、天冬氨酸转氨酶和碱性磷酸酶水平分别显著降低54.3%、44.6%和67.2%。在一项体外研究中,将大鼠肝细胞暴露于含有10 mM四氯化碳和不同浓度DDB-S(10或100 microg mL(-1))的新鲜培养基中。测定培养基中丙氨酸转氨酶和天冬氨酸转氨酶水平作为肝细胞损伤指标。与仅四氯化碳中毒相比,DDB-S剂量依赖性地降低了丙氨酸转氨酶和天冬氨酸转氨酶水平。这些结果表明DDB-S具有肝保护活性。